Search

Your search keyword '"Smith, Roger S."' showing total 313 results

Search Constraints

Start Over You searched for: Author "Smith, Roger S." Remove constraint Author: "Smith, Roger S."
313 results on '"Smith, Roger S."'

Search Results

4. An HSF1-JMJD6-HSP feedback circuit promotes cell adaptation to proteotoxic stress.

5. The Impact of Circadian Misalignment on Athletic Performance in Professional Football Players

6. The University--Some Differences from Other Organizations.

8. Data from Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers

9. Supplementary Figures from Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers

10. Supplementary Table from Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers

11. Supplementary Methods from Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers

15. Figure S4 from Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14–mutant Non–small Cell Lung Cancer

16. Supplementary Figure S1 from A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with ROS1-Rearranged Lung Cancer

17. Supplementary Figure 1 from Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors

18. Supplementary Figure 3 from Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors

19. Supplementary Figure Legends and Tables from A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with ROS1-Rearranged Lung Cancer

20. Supplemental Methods from Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors

21. Data from Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors

24. Supplementary Table 4 from Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors

25. Supplementary Figure 2 from Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors

26. Supplementary Table 1 from Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors

27. Supplementary Table 2 from Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors

28. Supplementary Table 3 from Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors

29. Supplementary Methods from Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14–mutant Non–small Cell Lung Cancer

30. Beyond BRCA: Discovery of novel causes and consequences of homologous recombination deficiencies

31. Obstructive Sleep Apnea in Adults

32. C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways

33. Dynamics of Pseudomonas aeruginosa Genome Evolution

34. HSF2 cooperates with HSF1 to drive a transcriptional program critical for the malignant state

35. Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling

36. Parent Education: Empowerment or Control?

Catalog

Books, media, physical & digital resources